Award
Delivery Order #75F40126F80143
FDA Orders Synensys to Develop a Biocompatibility Assessment Framework
Buyer
Food and Drug Administration
Award Amount
$2,448,445.47
Ceiling
$7,201,929.62
Period of Performance
Sep 15, 2026 – Sep 14, 2027
Identifier
75F40126F80143
NAICS
541612
The FDA issued Synensys, LLC a delivery order under the OASIS+ Service-Disabled Veteran-Owned Small Business multiple-award contract. Synensys is a service-disabled veteran-owned small business that provides integrated services to federal agencies; no parent company is identified. The work applies systems-theoretic methods—including STAMP, CAST, and STPA—to develop a candidate rubric for evaluating biocompatibility and begin establishing a learning regulatory system. These tools are intended to support more structured assessment and regulatory learning relevant to medical-product safety. The scope is focused on developing the assessment framework and initiating the regulatory-learning effort. The order is initially planned as a one-year effort, with potential work extending over several years. The OASIS+ contract vehicle is a multi-agency acquisition program; the available record does not identify the order’s competition method or provide a sole-source justification. No subcontractors, related prior contracts, or original solicitation details are provided. The record places performance in Peachtree City, Georgia.
Description
APPLICATION OF SYSTEMS-THEORETIC METHODS (STAMP / CAST / STPA) TO DEVELOP A CANDIDATE BIOCOMPATIBILITY ASSESSMENT RUBRIC AND INITIATE A LEARNING REGULATORY SYSTEM FOR BIOCOMPATIBILITY